EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vav2 is a master regulator of repair against bacterial pore-forming toxins

Victor Gbenga Kayejo, Ashlee Hensley, Tejal Katore, Peter A Keyel iD

Life Science Alliance · 2026-09 · 9 (9) · e202603633

DOI: 10.26508/lsa.202603633 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 09.07.2026. Verfasst von Victor Gbenga Kayejo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Texas Tech University, Lubbock, TX, USA. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-vav, Bacterial Toxins. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association-American Stroke Association, NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite antibiotic therapy, 25–35% of patients with necrotizing soft tissue infections (NSTIs) die. The etiologic agents for NSTIs include Streptococcus pyogenes and Clostridium perfringens , which secrete the cholesterol-dependent cytolysins (CDCs) streptolysin O and perfringolysin O to disrupt cell membranes. Whereas cells resist this damage by activating Ca 2+ -dependent repair pathways, including mitogen-activated protein kinase kinase (MEK)–dependent microvesicle shedding, dysferlin-mediated patch repair, and annexin-mediated membrane clogging, the upstream regulators of these responses have remained elusive. Here, we demonstrated that the Rac guanine nucleotide exchange factor Vav2 accounts for almost all of Ca 2+ -dependent repair against CDCs. Inhibiting or knocking down Vav2 sensitized multiple cell types to CDCs, whereas blocking other Rac guanine nucleotide exchange factors did not. Mechanistically, Vav2 triggered the critical mixed lineage kinase 3-MEK–dependent repair pathway. MEK activation rescued repair in Vav2-inhibited cells. Blocking dysferlin or annexins failed to increase damage beyond Vav2 inhibition, suggesting Vav2 coordinates multiple repair pathways. Thus, Vav2 controls multiple Ca 2+ -activated repair pathways that protect cells from CDCs produced during NSTIs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-vavBacterial ToxinsHumansStreptolysinsCalciumStreptococcus pyogenesHemolysin ProteinsAnimalsClostridium perfringensSignal TransductionCell MembraneBacterial Proteins

Substanzen

Proto-Oncogene Proteins c-vavBacterial ToxinsStreptolysinsVAV2 protein, humanCalciumstreptolysin OHemolysin ProteinsBacterial Proteins

Autor:innen und Institutionen

  • Department of Biological Sciences, Texas Tech University, Lubbock, TX, USA.
  • Department of Biological Sciences, Texas Tech University, Lubbock, TX, USA peter.keyel@ttu.edu.

ORCID-Profile: Peter A Keyel

Förderung

  • American Heart Association-American Stroke Association
  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • American Heart Association

Zitieren

APA

Kayejo, V. G., Hensley, A., Katore, T., & Keyel, P. A. (2026). Vav2 is a master regulator of repair against bacterial pore-forming toxins. Life Science Alliance, 9(9), e202603633. https://doi.org/10.26508/lsa.202603633

Vancouver

Kayejo VG, Hensley A, Katore T, Keyel PA. Vav2 is a master regulator of repair against bacterial pore-forming toxins. Life Science Alliance. 2026;9(9):e202603633. doi:10.26508/lsa.202603633

BibTeX
@article{Kayejo2026,
  author = {Kayejo, Victor Gbenga and Hensley, Ashlee and Katore, Tejal and Keyel, Peter A},
  title = {Vav2 is a master regulator of repair against bacterial pore-forming toxins},
  journal = {Life Science Alliance},
  year = {2026},
  volume = {9},
  number = {9},
  pages = {e202603633},
  doi = {10.26508/lsa.202603633}
}
Kostenlos starten →